We are dedicated to treating various retinal conditions but have a strong commitment to clinical research and actively support new and innovative treatments for retinal diseases.
Our dedicated research unit is currently involved in a number of local, national and international clinical trials and programs involving patients with Age-Related Macular Degeneration, Diabetic Macular Edema and Retinal Vein Occlusions. These studies are pivotal in quantifying the outcomes of current management and support the potential for future treatments.
Our retina specialists have wide-ranging experience in clinical trials and recognize the importance of research to promote understanding of eye disorders, investigate new therapeutic agents and advise patients on the best available treatment options.